Health Net Inc
Centene’s Hunt for New Growth Opportunities in Existing Markets
Centene believes that if all its existing markets adopt Medicaid expansion, it would result in 4 million additional members becoming eligible for Medicaid.
Centene’s Specialty Services Strategy Portfolio: Backbone or Achilles Heel?
Centene has developed a specialty services portfolio that reduces the company’s over-reliance on Medicaid and other state-sponsored businesses.
How Did Centene’s Geographical Diversification Strategy Boosts Pan out for Its 4Q15 Earnings?
Centene posted its 4Q15 and 2015 earnings on February 09 and reported diluted operating EPS attributable to common shareholders of about $2.89 for 2015.
Centene’s Revenue and Income Rose in 3Q15
Centene has reported net revenue of $5,821 million in 3Q15, an increase of 5.7% compared to $5,506 million in 2Q15. Operating revenue increased 5.8% in 3Q15.
Centene–Health Net Deal: Potential Risks
With the health insurance industry witnessing a wave of consolidations, it is expected that a majority of acquirers may risk overpaying for their targets.
Analyzing the Market’s Response to the Centene–Health Net Deal
The Centene–Health Net deal is expected to be completed by early 2016, pending approval by the shareholders of both companies.
Synergies in Centene’s Acquisition of Health Net
Centene projects that Health Net’s acquisition will help Centene realize pre-tax synergies worth $150 million by the end of the second year after the closure of the deal.
Centene Announces Its Acquisition of Health Net
On July 2, Centene announced the acquisition of Health Net for a combination of cash and shares amounting to $6.8 billion. This includes the assumption of Health Net’s $500 million debt.
The Aetna-Humana Deal: Must-Know Risks to Consider
On July 3, 2015, Aetna announced the acquisition of its peer, Humana (HUM), for a consideration of $37 billion.
Eminence Capital starts position in Cognizant Tech Solutions
Eminence Capital started a position in Cognizant Technology Solutions (CTSH) during 3Q14. The position accounts for 1.13% of the fund’s 3Q14 portfolio.
Avis Budget Group gets lower position with Iridian
Iridian lowered its position in Avis Budget Group, Inc. (CAR), which now accounts for 2.46% of the fund’s third-quarter portfolio.
Phillips 66 no longer part of Iridian
Iridian exited its position in Philips 66 (PSX), which accounts for 3.20% of the fund’s third quarter portfolio.
Sale of position in Tyco affects Iridian’s portfolio
Iridian sold its position in Tyco International Ltd. (TYC), which accounts for 1.90% of the fund’s second quarter portfolio.